[1]
“Method Of The Development And Validation For The Determination Of Atorvastatin In Both Bulk And Commercially Pharmaceutical Products”, Journal of Pharmaceutical Negative Results, pp. 5166–5172, Dec. 2022, doi: 10.47750/pnr.2022.13.S09.637.